Indicators | Weight value | Combined weight value | Maximum eigenvalue (max) | C.R. | Score |
---|---|---|---|---|---|
Domains | 3.0537 | 0.0517 | |||
1. Patient factors | 0.1976 | ||||
2. Disease factors | 0.4905 | ||||
3. Therapeutic factors | 0.3119 | ||||
Subdomains | |||||
1. Patient factors | 0.1976 | 4.0610 | 0.0229 | ||
1.1 basic feature | 0.2002 | 0.0396 | |||
1.2 complication | 0.3290 | 0.0650 | |||
1.3 Past medical history | 0.1418 | 0.0280 | |||
1.4 Inspection indicators | 0.3290 | 0.0650 | |||
2. Disease factors | 0.4905 | 3.0000 | 0.0000 | ||
2.1Tumor diagnosis time | 0.2500 | 0.1226 | |||
2.2Primary tumor site | 0.5000 | 0.2452 | |||
2.3Tumor staging | 0.2500 | 0.1226 | |||
3. Therapeutic factors | 0.3119 | 3.0183 | 0.0176 | ||
3.1medication | 0.5571 | 0.1738 | |||
3.2surgical treatment | 0.3202 | 0.0999 | |||
3.3Other treatments | 0.1226 | 0.0382 | |||
Indicators | |||||
1.1.1Asian population | 0.1153 | 0.0046 | -1 | ||
1.1.2 BMI>24 kg/m2 | 0.1492 | 0.0059 | 1 | ||
1.1.3 BMI ≥ 28 kg/m2 | 0.2442 | 0.0097 | 2 | ||
1.1.4 Age ≥ 60 years old | 0.3329 | 0.0132 | 1 | ||
1.1.5 female | 0.0792 | 0.0031 | 1 | ||
1.1.6Permanent residence: Plateau (≥ 2500 m) | 0.0792 | 0.0031 | 1 | ||
1.2.1 Decreased activity ability | 0.3290 | 0.0214 | 2 | ||
1.2.2 cardiovascular disease | 0.3290 | 0.0214 | 2 | ||
1.2.3 Lung or kidney disease | 0.2002 | 0.013 | 1 | ||
1.2.4 Severe infection | 0.1418 | 0.0092 | 1 | ||
1.3.1 VTE Personal History | 0.4893 | 0.0137 | 1 | ||
1.3.2 VTE Family History | 0.1381 | 0.0039 | 1 | ||
1.3.4 Hospitalization history (≤ 1 month) | 0.1381 | 0.0039 | 1 | ||
1.3.5 History of lower limb varicose veins | 0.2345 | 0.0066 | 1 | ||
1.4.1 D-Dimer ≥ 500ug/L | 0.5000 | 0.0325 | 3 | ||
1.4.2 Plt ≥ 350 × 109/L | 0.2500 | 0.0163 | 2 | ||
1.4.3 TAT>4ng/mL | 0.2500 | 0.0163 | 2 | ||
2.1.1Cancer diagnosis time ≤ 6months | 0.1226 | 0.0150 | 1 | ||
2.2.1 stomach | 0.2500 | 0.0613 | 6 | ||
2.2.2 pancreas | 0.2500 | 0.0613 | 6 | ||
2.2.3 lung | 0.1250 | 0.0307 | 3 | ||
2.2.4 lymphoma | 0.1250 | 0.0307 | 3 | ||
2.2.5 gynaecology | 0.1250 | 0.0307 | 3 | ||
2.2.6 urogenital system | 0.1250 | 0.0307 | 3 | ||
2.3.1 CancerCancer compresses blood vessels/lymphatic tissue | 0.3917 | 0.048 | 5 | ||
2.3.2 transfer | 0.2792 | 0.0342 | 3 | ||
2.3.3 Invasion of lymph nodes | 0.1646 | 0.0202 | 2 | ||
2.3.4Mediastinal involvement | 0.1646 | 0.0202 | 2 | ||
3.1.1 platinum | 0.0537 | 0.0093 | 1 | ||
3.1.2Hormonal replacement therapy | 0.1594 | 0.0277 | 3 | ||
3.1.3 High dose dexamethasone (≥ 160 mg/cycle) | 0.0981 | 0.017 | 2 | ||
3.1.4 Antiangiogenic drugs | 0.1035 | 0.018 | 2 | ||
3.1.5 Anticoagulants | 0.3233 | 0.0562 | -6 | ||
3.1.6 Adriamycin | 0.0790 | 0.0137 | 1 | ||
3.1.7 Erythropoietic stimulating factor | 0.1832 | 0.0318 | 3 | ||
3.2.1 Surgical site (hip or knee surgery) | 0.4905 | 0.049 | 5 | ||
3.2.2 Surgical time ≥ 2 h | 0.3119 | 0.0312 | 3 | ||
3.2.3 Surgical type (laparoscopic surgery, arthroscopic surgery) | 0.1976 | 0.0197 | 2 | ||
3.3.1 CVC | 0.0382 | 0.0015 | 1 |